BioSpace News Archive

Business

Real-Time Social Determinants of Health Solutions Now Available from LexisNexis

API delivery can help healthcare organizations improve health outcomes based on clinically validated social determinants of health

December 6, 2018
·
3 min read
A Look at the Latest Healthcare Industry Trends | Infiniti Research

Infiniti Research, a leading market intelligence company, has announced the completion of their latest article on the latest healthcare industry trends.

December 6, 2018
·
3 min read
BioForest

December AARP Bulletin Special Report: How to Never Run Out of Cash

AARP’s financial expert Jane Bryant Quinn reveals an easy-to-use formula - plus gives expert advice - for maintaining lifelong financial security

December 6, 2018
·
4 min read
Biotech Beach

The HydraFacial® Company Launches New Booster with SENTÉ®

The HydraFacial™ Company announced today an exciting new partnership with SENTÉ, an innovative specialty aesthetics company.

December 6, 2018
·
3 min read
Bio NC

Merz Encourages Women to Smash through Labels and Judgment with Disruptive New DTC Campaign for XEOMIN® (incobotulinumtoxinA)

Fresh campaign breaks traditional medical aesthetics marketing approach to stomp out the stigma and tap into a new segment of women, The Reclaimers

December 6, 2018
·
9 min read
Business

Shawna Gvazdauskas Appointed as Executive Vice President at Common Sensing

Common Sensing is the developer and manufacturer of the Gocap smart injectable medicine monitor

December 6, 2018
·
2 min read
Job Trends

NMI® at 60.7%; November Non-Manufacturing ISM® Report On Business®

Business Activity Index at 65.2%; New Orders Index at 62.5%; Employment Index at 58.4%

December 6, 2018
·
23 min read
Biotech Bay

Regal Medical Group Reminds 2018 Medicare Open Enrollment Period Coming to a Close December 7

The 2018 Medicare Open Enrollment Period will end on December 7, 2018. Eligible Medicare beneficiaries interested in obtaining coverage for the first time or enrolling in a different health plan have until tomorrow to finalize their health insurance for 2019.

December 6, 2018
·
1 min read
Drug Development

Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses

BYL719 plus fulvestrant meaningfully prolonged PFS vs fulvestrant alone in patients with PIK3CA mutated HR+/HER2- advanced breast cancer after progression on an aromatase inhibitor or after receiving up to one additional line of therapy1

December 6, 2018
·
10 min read
Business

CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing

The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries.

December 6, 2018
·
3 min read